Search

Your search keyword '"Cedric Pastoret"' showing total 47 results

Search Constraints

Start Over You searched for: Author "Cedric Pastoret" Remove constraint Author: "Cedric Pastoret"
47 results on '"Cedric Pastoret"'

Search Results

1. Vacuoles, E1 enzyme, X-linked, autoinflammatory, and somatic syndrome in the intensive care unit: a case report

2. P315: TP53 ALTERATIONS AND MRD REFINE PROGNOSIS OF ADULT KMT2A-REARRANGED B-ALL

3. High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALL

5. The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid Malignancies

6. IGHV segment utilization in immunoglobulin gene rearrangement differentiates patients with anti-myelin-associated glycoprotein neuropathy from others immunoglobulin M-gammopathies

7. Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia

8. Blinatumomab during Consolidation in High-Risk Philadelphia Chromosome (Ph)-Negative B-Cell Precursor (BCP) Acute Lymphoblastic Leukemia (ALL) Adult Patients: A Two-Cohort Comparison within the Graall-2014/B Study

9. In Adults with Ph-Negative Acute Lymphoblastic Leukemia (ALL), Age-Adapted Chemotherapy Intensity and MRD-Driven Transplant Indication Significantly Reduces Treatment-Related Mortality (TRM) and Improves Overall Survival - Results from the Graall-2014 Trial

10. A reduced panel of eight genes ( ATM , SF3B1 , NOTCH1 , BIRC3 , XPO1 , MYD88 , TNFAIP3 , and TP53 ) as an estimator of the tumor mutational burden in chronic lymphocytic leukemia

11. Thrombosis with Non-Proliferative Complete Blood Count Indicative of Underlying Myeloproliferative Neoplasm, Sythrom, a Study on Behalf of the FIM Group

12. Frontline Consolidation with Blinatumomab for High-Risk Philadelphia-Negative Acute Lymphoblastic Adult Patients. Early Results from the Graall-2014-QUEST Phase 2

13. High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALL

14. Ruxolitinib for refractory large granular lymphocyte leukemia

15. Reliable IGHV status assessment by next generation sequencing in routine practice for chronic lymphocytic leukemia

16. PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome

17. Apport du séquençage haut débit dans la prise en charge des hémopathies lymphoïdes

18. Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells

19. Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation

20. Redefining Therapeutic Drug Monitoring of Tacrolimus in Patients Undergoing Liver Transplantation: A Target Trough Concentration of 4-7 ng/mL During the First Month After Liver Transplantation is Safe and Improves Graft and Renal Function

21. Large Granular Lymphocyte Leukemia and Precapillary Pulmonary Hypertension

22. The Broad Spectrum of TP53 Variants in CLL: NGS Analysis of 573 Pathogenic TP53 Variants

23. 'Chronic myelogenous leukemia in primary blast crisis' rather than 'de novo BCR-ABL1 -positive acute myeloid leukemia'

24. Switches of tyrosine-kinase inhibitors in chronic phase of chronic myeloid leukemia in real life

25. Une anémie microcytaire sidéroblastique carentielle traitée efficacement par de la vitamine B6

26. Pan-HDAC Inhibitors Restore PRDM1 Response to IL21 in CREBBP-Mutated Follicular Lymphoma

27. The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid Malignancies

28. Hepatosplenic T-cell lymphoma displays an original oyster-shell cytological pattern and a genomic profile distinct from that of γδ T-cell large granular lymphocytic leukemia

29. Detection of clonal heterogeneity and targetable mutations in myeloid sarcoma by high-throughput sequencing

30. Discordant Response of Systemic Mastocytosis Associated With Myelodysplastic Syndrome After Midostaurin and Allogeneic Hematopoietic Stem-cell Transplantation

31. Pan-HDAC Inhibitors May Restore PRDM1 Expression in Follicular Lymphoma

32. Reference Values for WBC Differential by Hematoflow Analysis

33. Definition of a minimal genes set for mature lymphoid blood diseases

34. T-cell large granular lymphocytic leukemia

35. Targeted High-throughput Sequencing for Hematological Malignancies: A GBMHM Survey of Practice and Cost Evaluation in France

36. STAT3 mutation impacts biological and clinical features of T-LGL leukemia

37. Prospective, Multicentric Phase II Randomized Trial Comparing the Efficacy of Methotrexate or Cyclophosphamide in Large Granular Lymphocytic Leukemia: A French National Study. Report on the Interim Analysis

38. PF373 IMPACT OF ATM ALTERATIONS ON CHRONIC LYMPHOCYTIC LEUKEMIA IN GENERAL PRACTICE IN THE AREA OF NEXT GENERATION SEQUENCING

39. Integration of Immature Granulocytes Quantification With the Version 2.0 UniCel DxH 800 in the HematoFlow Strategy

40. Evaluation of FMH QuikQuant for the detection and quantification of fetomaternal hemorrhage

41. Diversity of TP53 Mutations in CLL: Retrospective Analysis of 450 Mutations from the French Innovative Leukemia Organization (FILO) Group

42. Mutations MYD88 L265P et CXCR4 WHIM-like dans les neuropathies anti-MAG

43. Comparaison des performances des techniques de cytogénétique conventionnelle (caryotype) et moléculaire (FISH, ACPA) pour l’étude cytogénétique des leucémies lymphoïdes chroniques au diagnostic

44. Toward a Better Classification System for NK-LGL Disorders

46. IL-2 imprints human naive B cell fate towards plasma cell through ERK/ELK1-mediated BACH2 repression

47. Early Response-Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia Study.

Catalog

Books, media, physical & digital resources